These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Long Non-Coding RNA HAND2 Antisense RNA 1 Inhibits Colorectal Cancer Development by Sponging microRNA-3118/Leptin Receptor Axis.
    Author: Yi C, Zhao C, Peng C.
    Journal: Ann Clin Lab Sci; 2023 Jan; 53(1):82-93. PubMed ID: 36889764.
    Abstract:
    OBJECTIVE: This study aimed to examine the function of long non-coding RNA HAND2 antisense RNA 1 (HAND2-AS1) in colorectal cancer (CRC) and explore its underlying mechanism of action. METHODS: HAND2-AS1, microRNA (miR)-3118, and leptin receptor (LEPR) levels were determined using western blot analysis and reverse transcription quantitative polymerase chain reaction (RT-qPCR). RNA-binding protein immunoprecipitation (RIP) and luciferase reporter assays were performed to evaluate the relationship between HAND2-AS1, miR-3118, and LEPR. Overexpression of genes in CRC cell lines was performed by transfection with the overexpression vector or miR-mimic. Cell proliferation, migration, and apoptosis-related protein levels were evaluated using the Cell Counting Kit-8 (CCK-8), Transwell, and western blotting assays. A CRC xenograft mouse model was established to verify the role of HAND2-AS1 in CRC in vivo. RESULTS: In both CRC cell lines and CRC tumor samples the HAND2-AS1 expression was reduced. Upregulation of HAND2-AS1 levels inhibited CRC cell line proliferation and migration, initiated apoptosis, and suppressed the growth of CRC xenografted tumors. In addition, HAND2-AS1 sponges miR-3118, which is up-regulated in CRC. Moreover, miR-3118 overexpression promoted CRC cell line proliferation along with cell migration, but hindered apoptosis of cells, along with altering the consequences of high expression levels of HAND2-AS1 in CRC cells. In addition, miR-3118 can target LEPR, which is downregulated in CRC. The effect of miR-3118 on CRC cells was blocked by LERP overexpression. CONCLUSION: HAND2-AS1 effectively inhibited CRC progression by sponging the miR-3118-LEPR axis. Our results may facilitate the development of therapeutic interventions for CRC.
    [Abstract] [Full Text] [Related] [New Search]